跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

SML2876

Sigma-Aldrich

DLCI-1

≥98% (HPLC)

别名:

5-(4-Ethyl-3-pyridinyl)-2-thiophenemethanamine, 5-(4-ethylpyridin-3-yl)thiophe-2-yl)methanamine

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C12H14N2S
CAS号:
2244569-14-8
分子量:
218.32
UNSPSC代码:
12352200
NACRES:
NA.77

质量水平

100

方案

≥98% (HPLC)

表单

oil

颜色

colorless to yellow

储存温度

2-8°C

SMILES字符串

[s]1c(ccc1c2cnccc2CC)CN

InChI key

PMFPLVYHUVJODG-UHFFFAOYSA-N

生化/生理作用

DLCI-1 is an orally available potent and selective inhibitor of cytochrome P450 2A6 (CYP2A6) that significantly decreases nicotine self-administration in both male and female mice.
orally available potent and selective inhibitor of CYP2A6 that significantly decreases nicotine self-administration mice

储存分类代码

11 - Combustible Solids

WGK

WGK 3

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Yen-Chu Chen et al.
The Journal of pharmacology and experimental therapeutics, 372(1), 21-29 (2019-10-20)
During tobacco and e-cigarette use, nicotine is mainly metabolized in the human liver by cytochrome P450 2A6 (CYP2A6). Given that a slower CYP2A6 metabolism has been associated with less vulnerability to develop nicotine dependence, the current studies sought to validate
Travis T Denton et al.
Journal of medicinal chemistry, 61(16), 7065-7086 (2018-07-12)
Cigarette smoking causes nearly one in every five deaths in the United States. The development of a specific inhibitor of cytochrome P450 2A6 (CYP2A6), the major nicotine-metabolizing enzyme in humans, which could be prescribed for the cessation of cigarette smoking

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门